查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2030043

次世代定序服務市場－全球產業規模、佔有率、趨勢、機會和預測：按服務、工作流程、最終用戶、地區和競爭對手分類，2021-2031年

Next Generation Sequencing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Workflow, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 177 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球次世代定序服務市場預計將從 2025 年的 60.9 億美元成長到 2031 年的 213.8 億美元，複合年成長率為 23.28%。

這些服務運用先進的高通量技術，精確辨識RNA和DNA分子中的核苷酸序列，涵蓋從樣本製備、文庫建構到實際定序和生物資訊分析的每一個步驟。這種調查方法能夠為廣泛的臨床和研究應用提供可靠、快速的遺傳資訊。該市場的成長主要得益於定序成本的持續下降、伴隨診斷和個人化醫療領域對這些服務日益成長的需求，以及平台技術的不斷改進，從而提高了測序的準確性和處理速度。

市場概覽
預測期 2027-2031
市場規模：2025年 60.9億美元
市場規模：2031年 213.8億美元
複合年成長率：2026-2031年 23.28%
成長最快的細分市場 數據分析
最大的市場 北美洲

正如全球基因組與健康聯盟 (GA4GH) 所展示的那樣，支撐這些服務的全球基因組網路以廣泛的合作為特徵。 2026 年 4 月，這個領先的產業組織指出，超過 500 家領先機構積極參與推動基因組數據的負責任使用。然而，儘管擁有如此強大的合作網路和顯著的市場成長，仍然存在阻礙進一步擴張的重大障礙。主要因素在於處理、分析和解讀這些平台產生的大量基因組資訊的複雜性和高昂成本，以及持續存在的倫理和資料隱私問題。

市場促進因素

全球次世代定序服務市場的關鍵促進因素之一是定序相關成本的持續下降。基因測序成本曾是一大障礙，但如今成本的降低正在擴大關鍵遺傳數據的取得途徑，並加速其在臨床和研究應用中的發展。這項轉變在技術升級中得到了清晰的體現，這些升級提高了定序通量並簡化了定序流程。例如，PacBio在2025年10月宣布，其改良的SPRQ-Nx定序技術旨在實現300美元以下的大規模高保真基因組分析，成本降低高達40%。這些成本效益的提升正在推動更廣泛的基因組研究，並加速定序技術融入標準診斷流程。

推動市場成長的另一個關鍵因素是伴隨診斷和精準醫療的日益普及。隨著醫療領域向個人化醫療轉型，這些定序服務在識別基因突變方面發揮著至關重要的作用，從而指導標靶治療並改善患者預後。這一趨勢在癌症治療領域尤為顯著。 Sermo 在 2026 年 2 月進行的一項調查顯示，35% 的醫生表示，腫瘤科是他們會考慮使用此類定序定序的首要臨床領域。基於定序的伴隨診斷的開發和監管核准能夠實現精準的患者分類，並增加了對全面基因組評估的需求。此外，政府的支持也凸顯了該領域的重要性，歐盟的「資助與招標入口網站」印證了這一點。該入口網站指出，基因組數據基礎設施計畫（Genomic Data Infrastructure project）正在建立一個跨境網路，整合各國基因組資料庫，該計畫已獲得超過 4,000 萬歐元的資金支持，預計將於 2026 年 10 月前完成。

市場挑戰

市場成長的主要障礙在於管理、分析和解讀這些定序平台所產生的大量基因組數據的複雜性和巨大成本。克服這一障礙需要對強大的技術基礎設施、客製化軟體解決方案以及一支訓練有素的生物資訊專業團隊進行大量投資。如此龐大的規模和錯綜複雜的遺傳資訊需要強大的運算資源和專家評估，這導致終端用戶和服務供應商都需承擔高昂的營運成本。

妥善管理基因組數據所需的巨額資金投入直接限制了這些定序服務的廣泛應用和擴充性。例如，歐盟委員會指出，旨在為歐洲提供安全存取臨床和基因組數據的基因組數據基礎設施（GDI）舉措，在2022年11月至2026年10月期間需要4000萬歐元的共同資助，這凸顯了構建關鍵數據處理系統的巨大成本。除了這些資金障礙外，對複雜數據分析的持續需求也使得小規模的臨床檢查室和研究機構對全面採用這些服務猶豫不決。因此，整體市場擴張受到阻礙，取得重要的基因組學發現也受到限制。

市場趨勢

在數據分析中採用先進的人工智慧 (AI) 和機器學習技術，透過最佳化複雜的生物資訊流程，顯著提升了定序服務的效率和價值。這項進步有助於克服解讀大量資料集的挑戰，並將原始基因資料快速轉化為可操作的應用。與傳統的人工計算方法相比，這些技術的整合能夠實現更卓越的變異檢測和模式識別。事實上，NVIDIA 在 2026 年 2 月進行的一項關於人工智慧在醫療保健和生命科學領域應用現狀的調查顯示，這些領域 70% 的專家目前已在其工作流程中使用人工智慧。這種廣泛的應用對於加速藥物研發和透過更深入地了解疾病路徑來實現個人化醫療至關重要。

另一個重要趨勢是多體學和單細胞定序技術的日益普及。與標準批量定序相比，這些技術能夠提供更詳盡的生物機制資訊。單細胞定序方法使科學家能夠研究細胞群間的多樣性，並以極高的清晰度識別稀有細胞。另一方面，多組體學策略整合了包括蛋白質組學和基因組學在內的不同生物學層面的訊息，從而提供疾病和細胞活動的全面觀點。這種整合方法在免疫學和腫瘤學等領域具有極高的價值，可用於追蹤疾病進展和治療反應。為了反映這一轉變，10x Genomics公司在2026年1月宣布，其單細胞耗材的銷售額年增超過20%。這表明這些先進技術正在被迅速採用，並凸顯了人們對這些技術所提供的精確生物學數據日益成長的需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球次世代定序服務市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 特定服務（人類基因組定序服務、單細胞定序服務、微生物基因組定序服務、基因表現調控服務等）
    • 工作流程分解（序列預處理、定序、資料分析）
    • 依最終用戶（醫院/診所、學術/研究機構、製藥/生技公司、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美次世代定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲次世代定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區次世代定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲次世代定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲次世代定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球次世代定序服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • PerkinElmer Inc.
  • Macrogen, Inc.
  • GENEWIZ, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 15173

The Global Next Generation Sequencing Services Market is anticipated to expand from USD 6.09 Billion in 2025 to USD 21.38 Billion by 2031, exhibiting a compound annual growth rate of 23.28%. These services involve applying advanced high-throughput technologies to identify the precise sequence of nucleotides in RNA or DNA molecules, covering everything from sample preparation and library building to the actual sequencing and bioinformatics assessment. This methodology delivers reliable and swift genetic insights for a variety of clinical and research applications. The growth of this market is primarily fueled by the steady decline in sequencing expenses, the growing incorporation of these services into companion diagnostics and personalized healthcare, and continuous improvements in platform technology that boost both precision and processing speed.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 6.09 Billion
Market Size 2031USD 21.38 Billion
CAGR 2026-203123.28%
Fastest Growing SegmentData Analysis
Largest MarketNorth America

Extensive collaboration defines the worldwide genomics network backing these services, as demonstrated by the Global Alliance for Genomics and Health (GA4GH). In April 2026, this major industry group noted that over 500 premier organizations are actively involved in promoting the responsible utilization of genomic data. Nevertheless, even with this strong collaborative spirit and impressive market growth, major obstacles continue to hinder broader expansion. Chief among these are the intricate nature and substantial expenses tied to processing, analyzing, and interpreting the massive volumes of genomic information produced by these platforms, compounded by ongoing ethical and data privacy concerns.

Market Driver

A major force propelling the Global Next Generation Sequencing Services Market is the steady decline in the costs associated with sequencing. While historically posing a formidable hurdle, the lowering expense of sequencing a genome has broadened access to vital genetic data, facilitating expanded clinical and research uses. This shift is clearly reflected in technological upgrades that improve throughput and simplify sequencing processes. As an example, PacBio announced in October 2025 that its updated SPRQ-Nx sequencing chemistry aims to produce a HiFi genome at scale for under $300, marking a cost decrease of up to 40%. These financial efficiencies facilitate more extensive genomic research, quickening the incorporation of sequencing technologies into standard diagnostic practices.

Another vital element stimulating market growth is the rising implementation of companion diagnostics and precision medicine. With the medical field moving toward individualized care, these sequencing services play an essential role in pinpointing genetic mutations that guide targeted treatments and enhance patient results. This trend is especially noticeable in cancer care; a February 2026 Sermo poll revealed that 35% of doctors cited oncology as the primary clinical setting for considering such sequencing tests. The creation and regulatory clearance of sequencing-backed companion diagnostics enable accurate patient categorization, driving the need for thorough genomic assessments. Furthermore, government backing highlights the significance of this sector, as seen on the European Union's Funding & Tenders Portal, which notes the Genomic Data Infrastructure project is operating with a budget exceeding 40 million EUR through October 2026 to establish a federated, cross-border network of national genome repositories.

Market Challenge

A major barrier to the growth of the market is the intricate nature and steep expenses linked to the management, analysis, and interpretation of the immense volumes of genomic data produced by these sequencing platforms. Overcoming this hurdle requires significant investments in solid technological infrastructure, tailored software solutions, and a team of expertly trained bioinformatics specialists. The massive scale and complex detail of this genetic information necessitate powerful computing resources and professional evaluation, resulting in heavy operational costs for end-users as well as service providers.

The massive financial commitment needed to properly manage genomic data acts as a direct limitation on the broad implementation and scalability of these sequencing services. For example, the European Commission points out that the Genomic Data Infrastructure (GDI) initiative, created to provide secure access to clinical and genomic data throughout Europe, requires a €40 million co-funding investment from November 2022 to October 2026, underscoring the hefty costs of establishing essential data handling systems. These monetary obstacles, combined with the continuous requirement for sophisticated data evaluation, often discourage smaller clinical labs and research facilities from fully adopting these services, which ultimately hinders the market's overall expansion and restricts wider access to critical genomic discoveries.

Market Trends

The incorporation of sophisticated Artificial Intelligence and Machine Learning into data analysis is drastically improving the effectiveness and value of sequencing services by optimizing complicated bioinformatics processes. This development helps overcome the difficulties of deciphering massive datasets, quickly turning unprocessed genetic data into practical applications. Integrating these technologies enables superior variant calling and pattern identification, surpassing traditional manual computing techniques. In fact, a February 2026 NVIDIA survey on the State of AI in Healthcare and Life Sciences indicated that 70% of professionals in these fields are currently utilizing AI within their workflows. Such extensive implementation is essential for speeding up pharmaceutical research and customizing medical treatments through a more profound comprehension of disease pathways.

Another crucial trend is the growing use of multiomic and single-cell sequencing techniques, which afford a much more detailed view of biological mechanisms compared to standard bulk sequencing. Single-cell methods empower scientists to investigate the diversity among cell groups and identify uncommon cells with exceptional clarity. Meanwhile, multiomic strategies combine information across different biological layers, including proteomics and genomics, to deliver a comprehensive perspective on diseases and cellular activities. This synthesized approach is exceptionally beneficial in disciplines such as immunology and oncology for tracking how diseases advance and how they react to therapies. Reflecting this shift, 10x Genomics noted in January 2026 that sales of single-cell consumables had risen by over 20% from the previous year, demonstrating the rapid adoption of these sophisticated methods and emphasizing the escalating need for the precise biological data they provide.

Key Market Players

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • PerkinElmer Inc.
  • Macrogen, Inc.
  • GENEWIZ, Inc.

Report Scope

In this report, the Global Next Generation Sequencing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing Services Market, By Service

  • Human Genome Sequencing Services
  • Single Cell Sequencing Services
  • Microbial Genome-based Sequencing Services
  • Gene Regulation Services
  • Others

Next Generation Sequencing Services Market, By Workflow

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Next Generation Sequencing Services Market, By End User

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Others

Next Generation Sequencing Services Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Services Market.

Available Customizations:

Global Next Generation Sequencing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Gene Regulation Services, Others)
    • 5.2.2. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
    • 5.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Next Generation Sequencing Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Workflow
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Workflow
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Next Generation Sequencing Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Workflow
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Next Generation Sequencing Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Workflow
        • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Workflow
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Next Generation Sequencing Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Workflow
        • 7.3.1.2.3. By End User
    • 7.3.2. France Next Generation Sequencing Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Workflow
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Workflow
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Next Generation Sequencing Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Workflow
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Next Generation Sequencing Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Workflow
        • 7.3.5.2.3. By End User

8. Asia Pacific Next Generation Sequencing Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Workflow
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Workflow
        • 8.3.1.2.3. By End User
    • 8.3.2. India Next Generation Sequencing Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Workflow
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Next Generation Sequencing Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Workflow
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Next Generation Sequencing Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Workflow
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Next Generation Sequencing Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Workflow
        • 8.3.5.2.3. By End User

9. Middle East & Africa Next Generation Sequencing Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Workflow
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Next Generation Sequencing Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Workflow
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Next Generation Sequencing Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Workflow
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Next Generation Sequencing Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Workflow
        • 9.3.3.2.3. By End User

10. South America Next Generation Sequencing Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Workflow
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Next Generation Sequencing Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Workflow
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Next Generation Sequencing Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Workflow
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Next Generation Sequencing Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Workflow
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Next Generation Sequencing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Illumina, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. QIAGEN N.V.
  • 15.4. BGI Genomics Co., Ltd.
  • 15.5. Eurofins Scientific SE
  • 15.6. F. Hoffmann-La Roche Ltd
  • 15.7. Agilent Technologies, Inc.
  • 15.8. PerkinElmer Inc.
  • 15.9. Macrogen, Inc.
  • 15.10. GENEWIZ, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer